Suppr超能文献

心脏再生细胞治疗的增强策略:以成体干细胞为重点。

Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells.

机构信息

From the Department of Biology, San Diego State University Heart Institute and the Integrated Regenerative Research Institute, CA.

出版信息

Circ Res. 2018 Jul 6;123(2):177-187. doi: 10.1161/CIRCRESAHA.118.311207.

Abstract

The idiom heart of the matter refers to the focal point within a topic and, with regard to health and longevity, the heart is truly pivotal for quality of life. Societal trends worldwide continue toward increased percent body fat and decreased physical activity with coincident increases in chronic diseases including cardiovascular disease as the top global cause of death along with insulin resistance, accelerated aging, cancer. Although long-term survival rates for cardiovascular disease patients are grim, intense research efforts continue to improve both prevention and treatment options. Pharmacological interventions remain the predominant interventional strategy for mitigating progression and managing symptoms, but cellular therapies have the potential to cure or even mediate remission of cardiovascular disease. Adult stem cells are the most studied cellular therapy in both preclinical and clinical investigation. This review will focus on the advanced therapeutic strategies to augment products and methods of delivery, which many think heralds the future of clinical investigations. Advanced preclinical strategies using adult stem cells are examined to promote synergism between preclinical and clinical research, streamline implementation, and improve this imminent matter of the heart.

摘要

成语“问题的核心”是指一个主题的焦点,就健康和长寿而言,心脏对于生活质量确实至关重要。全球社会趋势继续朝着体脂百分比增加和身体活动减少的方向发展,同时慢性疾病包括心血管疾病的发病率也在增加,心血管疾病是全球死亡的首要原因,此外还有胰岛素抵抗、加速衰老和癌症。尽管心血管疾病患者的长期生存率不容乐观,但仍在继续进行大量研究工作,以改善预防和治疗选择。药物干预仍然是减轻进展和管理症状的主要介入策略,但细胞疗法有可能治愈甚至缓解心血管疾病。成体干细胞是临床前和临床研究中研究最多的细胞疗法。本综述将重点介绍增强产品和输送方法的先进治疗策略,许多人认为这预示着临床研究的未来。本文探讨了使用成体干细胞的先进临床前策略,以促进临床前和临床研究之间的协同作用,简化实施,并改善这一迫在眉睫的问题。

相似文献

3
Adult stem cells: from new cell sources to changes in methodology.成体干细胞:从新的细胞来源到方法学的改变。
J Cardiovasc Transl Res. 2011 Apr;4(2):154-60. doi: 10.1007/s12265-010-9245-z. Epub 2010 Dec 2.
4
Regenerative medicine for the heart: perspectives on stem-cell therapy.心脏再生医学:干细胞治疗的前景
Antioxid Redox Signal. 2014 Nov 10;21(14):2018-31. doi: 10.1089/ars.2014.6063. Epub 2014 Sep 22.
5
The Unraveling of the Matryoshka Doll.套娃的拆解
Circ Res. 2017 Mar 31;120(7):1075-1077. doi: 10.1161/CIRCRESAHA.116.309904.
9
Therapeutic Application of Adult Stem Cells in the Heart.成体干细胞在心脏中的治疗应用。
Methods Mol Biol. 2017;1553:249-264. doi: 10.1007/978-1-4939-6756-8_20.
10
A Path Forward for Regenerative Medicine.再生医学的前进道路。
Circ Res. 2018 Aug 3;123(4):495-505. doi: 10.1161/CIRCRESAHA.118.313261.

引用本文的文献

7
Role of Stem-Cell Transplantation in Leukemia Treatment.干细胞移植在白血病治疗中的作用。
Stem Cells Cloning. 2020 Aug 10;13:67-77. doi: 10.2147/SCCAA.S262880. eCollection 2020.

本文引用的文献

1
A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration.同种异体干细胞组合促进心脏再生。
J Am Coll Cardiol. 2017 Nov 14;70(20):2504-2515. doi: 10.1016/j.jacc.2017.09.036.
3
Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit Cells.病理刺激决定心脏C-kit细胞的谱系定向
Circulation. 2017 Dec 12;136(24):2359-2372. doi: 10.1161/CIRCULATIONAHA.117.030137. Epub 2017 Oct 11.
7
Global position paper on cardiovascular regenerative medicine.心血管再生医学全球立场文件。
Eur Heart J. 2017 Sep 1;38(33):2532-2546. doi: 10.1093/eurheartj/ehx248.
8
Update on the Mechanisms of Liver Regeneration.肝脏再生的机制研究进展。
Semin Liver Dis. 2017 May;37(2):141-151. doi: 10.1055/s-0037-1601351. Epub 2017 May 31.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验